The present invention relates to a CD43 epitope expressed on human acute
leukemia and lymphoblastic lymphoma cells and its use. More particularly,
the present invention relates to a CD43 epitope expressed on human acute
leukemia, lymphoblastic lymphoma cells, but not on mature hematopoietic
cells, hematopoietic stem cells and non-hematopoietic cells, and to its
diagnostic and therapeutic application on acute leukemia and
lymphoblastic lymphoma.